Atlas Trials

Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid

Clinical trial NCT04777604 · UNKNOWN

Trial details

NCT number
NCT04777604
Sponsor
Samsung Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Pancreas Cancer
Start date
2021-03-01
Primary completion
2025-01-07
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.